Respirology Search
Respirology Respirology
rhinitis%20-%20nonallergic
RHINITIS - NONALLERGIC
Nonallergic rhinitis is the inflammation of the nasal lining membranes without any immunoglobulin E mediation, as documented by allergen skin testing.
Major signs and symptoms include nasal itching, watery rhinorrhea, nasal obstruction/congestion, sneezing and postnasal drainage.
Symptoms can reverse spontaneously with or without treatment.

Rhinitis%20-%20nonallergic Patient Education

Patient Education

  • Provide general information about the disease & available treatments
    • Manage patient’s expectations from therapy & explain that a complete cure may not be possible
  • Provide educational materials as necessary
  • Educate patient about the proper use of medications & possible side effects
    • Concomitant medications should also be reviewed to determine if the patient is taking drugs that may cause oral or nasal dryness
  • Lifestyle modifications such as proper hygiene & regular nasal rinsing
    • Good personal hygiene may minimize the risk of exposure to triggers (eg viruses, environmental irritants)
    • Nasal rinsing when done properly may assist in the absorption of nasal medications; See Nasal Saline Irrigation in the Pharmacotherapy section
  • Educate patient about the complications of rhinitis (eg otitis media & chronic sinusitis)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Are people with HIV at greater risk of COVID-19 mortality?
Roshini Claire Anthony, 02 Dec 2020

People with HIV (PWH) who are hospitalized due to COVID-19 may have an increased mortality risk, according to a study from the UK.
Ivermectin improves survival in COVID-19 patients with severe pulmonary involvement
21 Nov 2020
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
COVID-19 vaccine: A saviour, at last?
Pearl Toh, 19 Dec 2020
With the release of the latest interim efficacy results for ChAdOx1 nCoV-19, the adenovirus-vectored vaccine against COVID-19 is inching a step closer towards regulatory approval — and eventually, widespread use that will hopefully put an end to the relentless carnage by the pandemic.
Having asthma or allergy does not increase risk for severe COVID-19
Elvira Manzano, 12 Dec 2020
Having asthma or allergy does not make COVID-19 severe, a new study presented at ACAAI 2020 has shown.